<DOC>
	<DOC>NCT02853422</DOC>
	<brief_summary>The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.</brief_summary>
	<brief_title>Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours</brief_title>
	<detailed_description />
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<criteria>Patient with a diagnosis of gastrointestinal endocrine tumour. Patient able to read and understand the study questionnaires. Patient who has given informed consent in writing to take part in the study. Patient who is taking part in another clinical study during the study. Patients with another serious malignancy. Patients unable to meet the requirements of the protocol (noncompliant patients or those unfit to answer the questionnaires).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>